Canadian application, no grantCanada
Active enantiomer of rar.gamma.-specific agonist
CA 2344919 A1 · Owner: Tramposch, Kenneth M. · Inventors: Zusi, Fred C.; Belema, Makonen; Tramposch, Kenneth M.
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed is the (R)-enantiomer of formula (I) which has unexpectedly been , found to possess all of the biological activity of the racemic compound disclosed in the prior art as an RAR.gamma.-specific agonist.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 21, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 21, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 21, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 21, 1999
GrantedNo grant recorded
Term endedSeptember 21, 2019
Patent numberCA 2344919 A1
Classification (IPC)A61K31/19 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.